[Treatment of endometritis and salpingo-oophoritis monitored by the antilysozyme activity of the agents].
The authors suggest new methods for the choice of drugs and physiotherapeutic modalities for the treatment of female genital inflammations, based on the suppression of the agents' antilysozymic activities, factors of the agent intracellular persistence. Clinical trials of these methods in 91 patients have shown their high efficacy: the incidence of complete remissions has increased by 60.7%, incidence of disease recurrences reduced by 53%, and remission periods in chronic patients were prolonged by 2.5-3 times (from 0.5-1 year to 2.5-3 years).
Pervushina
L A
LA
Bukharin
O V
OV
Usviatsov
B Ia
BIa
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D004716:Endometritis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D009113:Muramidase / Q000187:drug effects*; D009869:Oophoritis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D012488:Salpingitis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D009113:Muramidase
Lechenie endometrita i sal'pingooforita pod kontrolem antilizotsimnoĭaktivnosti vozbuditelia.